Advertisement

Index by author

May 01, 1988; Volume 33,Issue 5

A

  1. Abel, P W

    1. Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.
      K P Minneman, C Han and P W Abel
      Molecular Pharmacology May 1988, 33 (5) 509-514;

  2. Amsterdam, P

    1. Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;

B

  1. Barnes, P J

    1. Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
      B M Grandordy, N Frossard, K J Rhoden and P J Barnes
      Molecular Pharmacology May 1988, 33 (5) 515-519;

  2. Bloomquist, J R

    1. Pyrethroid insecticides and DDT modify alkaloid-dependent sodium channel activation and its enhancement by sea anemone toxin.
      J R Bloomquist and D M Soderlund
      Molecular Pharmacology May 1988, 33 (5) 543-550;

  3. Bolard, J

    1. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
      N Henry-Toulme, B Stefanska, E Borowski and J Bolard
      Molecular Pharmacology May 1988, 33 (5) 574-579;

  4. Borowski, E

    1. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
      N Henry-Toulme, B Stefanska, E Borowski and J Bolard
      Molecular Pharmacology May 1988, 33 (5) 574-579;

C

  1. Cox, B M

    1. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
      P S Puttfarcken, L L Werling and B M Cox
      Molecular Pharmacology May 1988, 33 (5) 520-527;

  2. Crooke, S T

    1. Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
      R V Vegesna, H L Wu, S Mong and S T Crooke
      Molecular Pharmacology May 1988, 33 (5) 537-542;

F

  1. Farb, D H

    1. Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.
      D J Roca, G D Schiller and D H Farb
      Molecular Pharmacology May 1988, 33 (5) 481-485;

  2. Frossard, N

    1. Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
      B M Grandordy, N Frossard, K J Rhoden and P J Barnes
      Molecular Pharmacology May 1988, 33 (5) 515-519;

G

  1. George, S T

    1. Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.
      C P Moxham, E M Ross, S T George and C C Malbon
      Molecular Pharmacology May 1988, 33 (5) 486-492;

  2. Grandordy, B M

    1. Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
      B M Grandordy, N Frossard, K J Rhoden and P J Barnes
      Molecular Pharmacology May 1988, 33 (5) 515-519;

  3. Grunwald, R

    1. Interaction of the antifolate antibiotic trimethoprim with phosphatidylcholine membranes: a 13C and 31P nuclear magnetic resonance study.
      G R Painter, R Grunwald and B Roth
      Molecular Pharmacology May 1988, 33 (5) 551-558;

  4. Guengerich, F P

    1. Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.
      F P Guengerich
      Molecular Pharmacology May 1988, 33 (5) 500-508;

H

  1. Han, C

    1. Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.
      K P Minneman, C Han and P W Abel
      Molecular Pharmacology May 1988, 33 (5) 509-514;

  2. Henry-Toulme, N

    1. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
      N Henry-Toulme, B Stefanska, E Borowski and J Bolard
      Molecular Pharmacology May 1988, 33 (5) 574-579;

J

  1. Johnson, E F

    1. Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.
      G E Schwab, J L Raucy and E F Johnson
      Molecular Pharmacology May 1988, 33 (5) 493-499;

K

  1. Keys, C

    1. Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;

L

  1. Loew, G

    1. Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;

  2. London, R E

    1. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 559-566;
    2. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. II. A reevaluation of hepatic metabolic pathways.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 567-573;

M

  1. Malbon, C C

    1. Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.
      C P Moxham, E M Ross, S T George and C C Malbon
      Molecular Pharmacology May 1988, 33 (5) 486-492;

  2. Minneman, K P

    1. Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.
      K P Minneman, C Han and P W Abel
      Molecular Pharmacology May 1988, 33 (5) 509-514;

  3. Mong, S

    1. Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
      R V Vegesna, H L Wu, S Mong and S T Crooke
      Molecular Pharmacology May 1988, 33 (5) 537-542;

  4. Moxham, C P

    1. Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.
      C P Moxham, E M Ross, S T George and C C Malbon
      Molecular Pharmacology May 1988, 33 (5) 486-492;

P

  1. Painter, G R

    1. Interaction of the antifolate antibiotic trimethoprim with phosphatidylcholine membranes: a 13C and 31P nuclear magnetic resonance study.
      G R Painter, R Grunwald and B Roth
      Molecular Pharmacology May 1988, 33 (5) 551-558;

  2. Payne, P

    1. Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;

  3. Perlman, M E

    1. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 559-566;
    2. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. II. A reevaluation of hepatic metabolic pathways.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 567-573;

  4. Puttfarcken, P S

    1. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
      P S Puttfarcken, L L Werling and B M Cox
      Molecular Pharmacology May 1988, 33 (5) 520-527;

R

  1. Raucy, J L

    1. Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.
      G E Schwab, J L Raucy and E F Johnson
      Molecular Pharmacology May 1988, 33 (5) 493-499;

  2. Rhoden, K J

    1. Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
      B M Grandordy, N Frossard, K J Rhoden and P J Barnes
      Molecular Pharmacology May 1988, 33 (5) 515-519;

  3. Roca, D J

    1. Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.
      D J Roca, G D Schiller and D H Farb
      Molecular Pharmacology May 1988, 33 (5) 481-485;

  4. Ross, E M

    1. Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.
      C P Moxham, E M Ross, S T George and C C Malbon
      Molecular Pharmacology May 1988, 33 (5) 486-492;

  5. Roth, B

    1. Interaction of the antifolate antibiotic trimethoprim with phosphatidylcholine membranes: a 13C and 31P nuclear magnetic resonance study.
      G R Painter, R Grunwald and B Roth
      Molecular Pharmacology May 1988, 33 (5) 551-558;

S

  1. Schiller, G D

    1. Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.
      D J Roca, G D Schiller and D H Farb
      Molecular Pharmacology May 1988, 33 (5) 481-485;

  2. Schwab, G E

    1. Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.
      G E Schwab, J L Raucy and E F Johnson
      Molecular Pharmacology May 1988, 33 (5) 493-499;

  3. Selinsky, B S

    1. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 559-566;
    2. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. II. A reevaluation of hepatic metabolic pathways.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 567-573;

  4. Soderlund, D M

    1. Pyrethroid insecticides and DDT modify alkaloid-dependent sodium channel activation and its enhancement by sea anemone toxin.
      J R Bloomquist and D M Soderlund
      Molecular Pharmacology May 1988, 33 (5) 543-550;

  5. Stefanska, B

    1. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
      N Henry-Toulme, B Stefanska, E Borowski and J Bolard
      Molecular Pharmacology May 1988, 33 (5) 574-579;

T

  1. Toll, L

    1. Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;

V

  1. Vegesna, R V

    1. Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
      R V Vegesna, H L Wu, S Mong and S T Crooke
      Molecular Pharmacology May 1988, 33 (5) 537-542;

W

  1. Werling, L L

    1. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
      P S Puttfarcken, L L Werling and B M Cox
      Molecular Pharmacology May 1988, 33 (5) 520-527;

  2. Wu, H L

    1. Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
      R V Vegesna, H L Wu, S Mong and S T Crooke
      Molecular Pharmacology May 1988, 33 (5) 537-542;
Back to top

In this issue